| Endometrial Adenosquamous Carcinoma studied in …STUDIED_INderived12 of 12show fewer |
|---|
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307631Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132820Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011933Phase 2 · completed Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005329Phase 2 · completed Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01210222Phase 2 · completed Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00820898Phase 2 · completed Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00575952Phase 1 · completed Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064025Phase 2 · completed Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006011Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (1 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |